Evaluation of Intravenous Dalbavancin for Treatment of Peritonitis in Peritoneal Dialysis Patients
Latest Information Update: 13 May 2024
At a glance
- Drugs Dalbavancin (Primary)
- Indications Bacterial peritonitis; Gram-positive infections
- Focus Therapeutic Use
- 07 May 2024 Status changed from recruiting to discontinued. (Slow recruitment)
- 22 Feb 2022 Planned End Date changed from 30 Sep 2021 to 30 Jun 2024.
- 22 Feb 2022 Planned primary completion date changed from 30 Sep 2021 to 31 Dec 2023.